Wang Pengpeng, Yang Yongli, Wang Sihua, Duan Xiaoran, Wang Tuanwei, Feng Xiaolei, Yan Zhen, Wu Yongjun, Yu Songcheng, Wang Wei
Department of Occupational Health Occupational Disease, College of Public Health, Zhengzhou University, Zhengzhou, China.
Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, China.
J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22171. Epub 2017 Feb 23.
Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) is a common and mature method of detecting the single nucleotide polymorphism (SNP). But, for the polymorphism site rs3863242 of telomeric repeat binding factor 1(TERF1) gene, there is no appropriate restriction enzyme to recognize it, which limits the research between the variants of rs3863242 and human diseases.
The reverse primer was designed based on turning the 3rd base T into the mismatch base G. After PCR amplification, a new restriction enzyme site was introduced into the TERF1 gene amplification products. Two hundred forty samples from Chinese Han individuals were genotyped to evaluate this method.
A new restriction enzyme site for CviQI was introduced into the PCR products. The genotype frequencies of 240 samples from Chinese Han individuals were 4.17% for A/A, 29.58% for A/G, 66.25% for G/G respectively. The allele frequencies were 18.96% for A and 81.04% for G respectively. The genotyping results of PCR products were consistent with the gene sequencing result.
We developed a simple, direct and economical technique for analyzing the polymorphism of TERF1 rs3863242. It may be applied to the colony screening of other SNPs, mutation-screening of tumor-related gene or mutations in some specific genes on a large scale, in the future.
聚合酶链反应-限制性片段长度多态性(PCR-RFLP)是检测单核苷酸多态性(SNP)的一种常用且成熟的方法。但是,对于端粒重复结合因子1(TERF1)基因的多态性位点rs3863242,没有合适的限制性内切酶来识别它,这限制了rs3863242变体与人类疾病之间的研究。
基于将第3个碱基T转变为错配碱基G来设计反向引物。PCR扩增后,在TERF1基因扩增产物中引入一个新的限制性酶切位点。对240例中国汉族个体的样本进行基因分型以评估该方法。
在PCR产物中引入了一个针对CviQI的新限制性酶切位点。240例中国汉族个体样本的基因型频率分别为:A/A为4.17%,A/G为29.58%,G/G为66.25%。等位基因频率分别为:A为18.96%,G为81.04%。PCR产物的基因分型结果与基因测序结果一致。
我们开发了一种简单、直接且经济的技术来分析TERF1 rs3863242的多态性。未来它可能应用于其他SNP的群体筛查、肿瘤相关基因的突变筛查或某些特定基因的大规模突变筛查。